182 related articles for article (PubMed ID: 9934077)
1. Recent developments in respiratory care pharmacology.
Rau JL
J Perianesth Nurs; 1998 Dec; 13(6):359-69. PubMed ID: 9934077
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in pulmonary pharmacology.
Papich MG
Semin Vet Med Surg Small Anim; 1986 Nov; 1(4):289-301. PubMed ID: 3321289
[No Abstract] [Full Text] [Related]
3. [Inhalation therapy].
None LV; Lemarié E; Diot P
Rev Infirm; 2006 Feb; (118):16-23. PubMed ID: 16562547
[No Abstract] [Full Text] [Related]
4. Adjunctive pharmacotherapy in neonates with respiratory failure.
Fok TF
Semin Fetal Neonatal Med; 2009 Feb; 14(1):49-55. PubMed ID: 18851933
[TBL] [Abstract][Full Text] [Related]
5. [Aerosol therapy].
Wildhaber JH
Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
[TBL] [Abstract][Full Text] [Related]
6. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
Heijerman H; Westerman E; Conway S; Touw D; Döring G;
J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bronchodilators and mucolytic agents.
Kamat SR
J Postgrad Med; 1979 Jan; 25(1):1-3. PubMed ID: 458736
[No Abstract] [Full Text] [Related]
8. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
9. General factors influencing drug delivery to the lung.
Ganderton D
Respir Med; 1997 Nov; 91 Suppl A():13-6. PubMed ID: 9474361
[TBL] [Abstract][Full Text] [Related]
10. Respiratory pharmacology and the weaning patient: implications for critical care nursing.
Ryan B; Luer JM
AACN Clin Issues Crit Care Nurs; 1991 Aug; 2(3):361-71. PubMed ID: 1873113
[TBL] [Abstract][Full Text] [Related]
11. Drugs affecting the respiratory system.
Boothe DM
Vet Clin North Am Exot Anim Pract; 2000 May; 3(2):371-94, v. PubMed ID: 11228884
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
Ilowite J; Spiegler P; Kessler H
Drugs; 2009; 69(4):407-19. PubMed ID: 19323585
[TBL] [Abstract][Full Text] [Related]
13. [Respiratory preparation for surgical intervention. General principles and methods].
Scherpereel P
Anesth Analg (Paris); 1978; 35(4):625-34. PubMed ID: 727538
[No Abstract] [Full Text] [Related]
14. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
15. [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Le Roux P; Le Luyer B
Arch Pediatr; 2003 Sep; 10 Suppl 2():358s-363s. PubMed ID: 14671935
[TBL] [Abstract][Full Text] [Related]
16. Aerosol Therapy in Pulmonary Critical Care.
Ari A
Respir Care; 2015 Jun; 60(6):858-74; discussion 874-9. PubMed ID: 26070580
[TBL] [Abstract][Full Text] [Related]
17. The inhalation of drugs: advantages and problems.
Rau JL
Respir Care; 2005 Mar; 50(3):367-82. PubMed ID: 15737247
[TBL] [Abstract][Full Text] [Related]
18. Comparison of inhaled corticosteroids.
Kelly HW
Ann Pharmacother; 1998 Feb; 32(2):220-32. PubMed ID: 9496409
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.
Ferguson GT; Dalby RN
Postgrad Med; 2018 Aug; 130(6):515-522. PubMed ID: 29972656
[TBL] [Abstract][Full Text] [Related]
20. Long-term management of reversible obstructive airways disease in adults.
Lurie A; Vlastos FD; Dusser DJ; Strauch G; Marsac J
Lung; 1990; 168 Suppl():154-67. PubMed ID: 1974671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
